基本信息
views: 2
Career Trajectory
Bio
Dr. Asmatullah: born in S.Wazirstan, KPK Pakistan. Completed D-Pharm and M.Phil in 2008-13 and 2014-16 from Gomal University D.I.Khan Respectively, Ph.D. (Pharmacology) in 2017-21 from Xi’an Jiaotong University China. I worked on Natural Alkaloidal Agents against Hypoxic therapy in lung cancer. I also focus on the drug delivery system and polymer's role in drug delivery. My interest area is the effect of drug delivery on the molecular level in cancer.
Skills and expertise
Hypoxia, PCR, Cell Hypoxia, Immunofluorescence, Cell Culture, Immunohistochemistry, Western Blot, Analysis ROS Measurement, Cell Signaling, Cellular Biology, Flow Cytometry, Cell Viability, ELISA, Apoptosis, intracellular pH
Research Interests
Papers共 32 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current protein & peptide scienceno. 5 (2024): 376-385
Naveed Ullah Khan, Xie Chengfeng, Meng-Qin Jiang,Zaheer Ullah Khan,Anam Razzaq,Asmat Ullah,Jiang Ni, Abdullah,Haroon Iqbal, Zhi Min Jin
International Journal of Biological Macromolecules (2024): 134166-134166
crossref(2024)
Current protein & peptide scienceno. 3 (2024): 244-255
Current molecular pharmacology (2024): e18761429269383-e18761429269383
Moleculesno. 6442 (2023): 6442
Current stem cell research & therapy (2023)
Najeeb Ullah,Beenish Noureen,Qurat Ul Ain Zahra,Tariq Aziz,Somia Shehzadi, Mohammad Y. Alfaifif, Serag Eldin I. Elbehairif,Khalid Hussain Thebo,Asmat Ullah,Haroon Iqbal
CURRENT ANALYTICAL CHEMISTRYno. 9 (2023): 677-684
Load More
Author Statistics
#Papers: 31
#Citation: 517
H-Index: 16
G-Index: 22
Sociability: 5
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn